NBC Securities
TGTX icon

NBC Securities’s TG Therapeutics TGTX Stock Holding History

NBC Securities’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$151K Buy
2,712
+2,191
+421% +$119K 0.01% 953
2026
Q2 		$28.6K Hold
521
– – ﹤0.01% 1510
2026
Q1 		$17.3K Hold
521
– – ﹤0.01% 1762
2025
Q4 		$15.5K Hold
521
– – ﹤0.01% 1871
2025
Q3 		$18.8K Sell
521
-2,503
-83% -$82.4K ﹤0.01% 1770
2025
Q2 		$108K Buy
3,024
+2,200
+267% +$81.9K 0.01% 1017
2025
Q1 		$32K Buy
824
+823
+82,300% +$27.7K ﹤0.01% 1307
2024
Q4 		$39 Sell
1
-1,308
-100% -$37.5K ﹤0.01% 1077
2024
Q3 		$30K Buy
1,309
+485
+59% +$10.6K ﹤0.01% 1349
2024
Q2 		$14K Hold
824
– – ﹤0.01% 1576
2024
Q1 		$12K Sell
824
-8,577
-91% -$137K ﹤0.01% 1640
2023
Q4 		$160K Buy
9,401
+2,409
+34% +$28K 0.02% 808
2023
Q3 		$58K Buy
+6,992
New +$97.5K 0.01% 1082

Other funds holding TGTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

NBC Securities's TGTX Position: Q3 2026 in Review

NBC Securities increased its TG Therapeutics (TGTX) stake by 421% in Q3 2026, buying an estimated $119K and bringing the position to 2,712 shares worth $151K. The position accounts for 0.01% of the portfolio, ranked #953.

NBC Securities first reported a position in TGTX in Q3 2023 and has held it in 13 quarters since. The position peaked at $160K in Q4 2023. 215 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • NBC Securities held 2,712 shares of TG Therapeutics worth $151K as of Q3 2026.
  • NBC Securities bought 2,191 TG Therapeutics shares in Q3 2026, an estimated $119K.
  • TG Therapeutics made up 0.01% of NBC Securities's portfolio in Q3 2026, its #953 holding.
  • NBC Securities first reported a position in TG Therapeutics in Q3 2023 and has held it in 13 quarters since.
  • NBC Securities's TG Therapeutics position peaked at $160K in Q4 2023.
  • 215 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.